Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vaccine Effectiveness × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Sarcoma 3 Multiple Myeloma 3 Glioma 3 Myasthenia Gravis 2 Melanoma 2 Lung Neoplasms 2 Heart Failure 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Vaccine Effectiveness 1 Tuberous Sclerosis 1 Thyroid Nodule 1 Stomatitis 1 Stomach Ulcer 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Peptic Ulcer Hemorrhage 1 Pain 1 Oligodendroglioma 1 Odontogenic Cysts 1 Neuroinflammatory Diseases 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡